Chlamydia pneumoniae and Mycoplasma pneumoniae in calcified nodes of stenosed aortic valves;Chlamydia pneumoniae e Mycoplasma pneumoniae nos nódulos de calcificação da estenose da valva aórtica

Arquivos Brasileiros de Cardiologia

Volumn 84, Issue 6, 2005, Pages 443-448

  Higuchi Dos Santos, Marilia Harumi ^a,b   Pierri, Humberto ^a   De Lourdes Higuchi, Maria ^a   Nussbacher, Amit ^a   Palomino, Sueli ^a   Vieira Sambiase, Nadia ^a   Franchini Ramires, José Antonio ^a   Wajngarten, Maurício ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b Rua Capote Valente   (Brazil)

Author keywords

Aortic Valve Stenosis; Atherosclerosis; Chlamydia pneumoniae; Elderly; Mycoplasma pneumoniae

Indexed keywords

BACTERIAL ANTIGEN; BACTERIAL DNA;

ADULT; AGED; AORTA ATHEROSCLEROSIS; AORTA VALVE STENOSIS; ARTERY CALCIFICATION; ARTICLE; AUTOPSY; CHLAMYDOPHILA PNEUMONIAE; CLINICAL ARTICLE; ELECTRON MICROSCOPY; FEMALE; FIBROSIS; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; INFLAMMATION; MALE; MYCOPLASMA PNEUMONIAE;

EID: 21044431750     PISSN: 0066782X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. Otto CM, Kuusisto J, Reichenbach DD, Gown AM, O'Brien KD. Characterization of the early lesion of 'degenerative' aortic stenosis. Histological and immunohistochemical studies. Circulation 1994; 90: 844-53.
2. Pohle K, Mäffert R, Ropers D et al. Progression of aortic valve calcification - Association with coronary atherosclerosis and cardiovascular risk factors. Circulation 2001; 104: 1927-32.
3. Stewart BF, Siscovick D, Lind BK et al. Clinical factors associated with calcific aortic valve disease. Cardiovascular Health Study. J Am Coll Cardiol 1997; 29: 630-4.
4. Mohler ER, Sheridan MJ, Nichols R, Harvey WP, Waller BF. Development and progression of aortic valve stenosis: atherosclerosis risk factors-a causal relationship? A clinical morphologic study. Clin Cardiol 1991; 14: 995-9.
5. Aronow WS, Schwartz KS, Koenigsberg M. Correlation of serum lipids, calcium, and phosphorus, diabetes mellitus and history of systemic hypertension with presence or absence of calcified or thickened aortic cusps or root in elderly patients. Am J Cardiol 1987; 59: 998-9.
6. Otto CM, O'Brien KD. Why is there discordance between calcific aortic stenosis and coronary artery disease? Heart 2001; 85: 601-2.
7. Juvonen J, Juvonen T, Laurila A et al. Can degenerative aortic valve stenosis be related to persistent Chlamydia pneumoniae infection? Ann Intern Med 1998; 128: 741-4.
8. O'Brien KD, Reichenbach DD, Marcovina SM, Kuusisto J, Alpers CE, Otto CM. Apolipoproteins B, (a), and E accumulate in the morphologically early lesion of 'degenerative' valvular aortic stenosis. Arterioscler Thromb Vasc Biol 1996; 16: 523-32.
9. Andreasen JJ, Farholt S, Jensen JS. Failure to detect Chlamydia pneumoniae in calcific and degenerative arteriosclerotic aortic valves excised during open heart surgery. APMIS 1998; 106: 717-20.
10. Oliveira SA, Mansur AP, Ribeiro CC, Ramires JA, Annichino-Bizzacchi JM. PON1 M/L55 mutation protects high-risk patients against coronary artery disease. Int J Cardiol 2004; 94: 73-7.
11. Ortlepp JR, Hoffmann R, Ohme F, Lauscher J, Bleckmann F, Hanrath P. The vitamin D receptor genotype predisposes to the development of calcific aortic valve stenosis. Heart. 2001; 85: 635-8.
12. Ohmori R, Momiyama Y, Taniguchi H et al. Plasma osteopontin levels are associated with the presence and extent of coronary artery disease. Atherosclerosis 2003; 170: 333-7.
13. O'Brien KD, Kuusisto J, Reichenbach DD et al. Osteopontin is expressed in human aortic valvular lesions. Circulation 1995; 92: 2163-8.
14. Momiyama Y, Hirano R, Taniguchi H, Nakamura H, Ohsuzu F. Effects of interleukin-1 gene polymorphisms on the development of coronary artery disease associated with Chlamydia pneumoniae infection. J Am Coll Cardiol 2001; 38: 712-7.
15. Higuchi M de L, Reis MM, Sambiase NV et al. Coinfection with Mycoplasma pneumoniae and Chlamydia pneumoniae in ruptured plaques associated with acute myocardial infarction. Arq Bras Cardiol 2003; 81: 12-22, 1-11.
16. Juvonen J, Laurila A, Juvonen T et al. Detection of Chlamydia pneumoniae in human nonrheumatic stenotic aortic valves. J Am Coll Cardiol 1997; 29: 1054-9.
17. Higuchi ML, Sambiase N, Palomino S et al. Detection of Mycoplasma pneumoniae and Chlamydia pneumoniae in ruptured atherosclerotic plaques. Braz J Med Biol Res 2000; 33: 1023-6.
18. Higuchi ML, Castelli JB, Aiello VD et al. Great amount of Chlamydia pneumoniae in ruptured plaque vessel segments at autopsy. A comparative study of stabela plaques. Arq Bras Cardiol 2000; 74: 149-51.
19. Nystrom-Rosander C, Thelin S, Hjelm E, Lindquist O, Pahlson C, Friman G. High incidence of Chlamydia pneumonias in sclerotic heart valves of patients undergoing aortic valve replacement. Scand J Infect Dis 1997; 29: 361-5.
20. Reynolds ES. The use of lead citrate at high pH as an electron-opaque stain in electron microscope. J Cell Biol 1963; 17: 208-12.
21. Rosner B. Fundamentals of Biostatistics. 2nd ed. Boston: PWS Publishers; 1986.
22. Mohler ER, Gannon F, Reynolds C, Zimmerman R, Keane MG, Kaplan FS. Bone formation and inflammation in cardiac valves. Circulation 2001; 103: 1522-8.
23. Noordhlek GT, van Embden JD, Am Kolk AH. Reliability of nucleic acid amplification for detection of Mycobacterium tuberculosis: an international collaborative quality control study among 30 laboratories. J Clin Microbiol 1996; 34: 2522-5.
24. Van Vliet KE, Muir P, Echevarria JM, Klapper PE, Cleator GM, van Loon AM. Multicenter proficiency testing of nucleic acid amplicification methods for the detection of enteroviruses. J Clin Microbiol 2001; 39: 3390-2.
25. Vehmaan-Kreula P, Poulakkainen M, Sarvas M, Velgus HG, Kovanen RT. Chlamydia pneumoniae proteins induce secretion of the 92-kDa gelatinase by human monocyte-derived macrophages. Arterioscler Thromb Vasc Biol 2001; 21: e1-e8.
26. Skowasch D, Yeghiazaryan K, Schrempf S et al. Persistence of Chlamydia pneumoniae in degenerative aortic valvestenosis indicated by heat shock protein 60 homologues. J Heart Valve Dis 2003; 12: 68-75.
27. Razin S, Yogev D, Naot Y. Molecular biology and pathogenicity of mycoplasmas. Microbiol Mol Biol Rev 1998; 62: 1094-156.
28. Olsson M, Thyberg J, Nilsson J. Presence of oxidized low density lipoprotein in nonrheumatic stenotic aortic valves. Arterioscler Thromb Vasc Biol 1999; 19: 1218-22.
29. Galante A, Pietroiusti A, Vellini M et al. C-reactive protein is increased in patients with degenerative aortic valvular stenosis. J Am Coll Cardiol 2001; 38: 1078-82.